Merck & Co. | Campral (Medication)
Campral/acamprosate is indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation. Treatment with Campral should be part of a comprehensive management program that includes psychosocial support.
The recommended dose of Campral is two 333 mg tablets (each dose should total 666 mg) taken three times daily. A lower dose may be effective in some patients. ...
Clinically significant serious adverse reactions associated with Campral described elsewhere in labeling include suicidality and depression and acute kidney failure.
Patients taking Campral concomitantly with antidepressants more commonly reported both weight gain and weight loss, compared with patients taking either medication alone. ...
You should not use Campral if you are allergic to acamprosate, or if you have severe kidney disease. Campral will not treat or prevent alcohol withdrawal symptoms.
Before you take Campral, tell your doctor if you have any type of kidney problem. You may need a dose adjustment or special tests to safely use this medication.
You may have thoughts about suicide while you are taking Campral. Tell your doctor if you feel depressed or have any suicidal thoughts or actions during treatment.
Your family or other caregivers should also be alert to changes in your mood or behavior. Make sure your caregivers know how to contact your doctor in case you have mood changes or suicidal thoughts or actions.
During pregnancy and breastfeeding is not recommended to use this medicine without your doctor's advice. ...